The Prevalence of Tandem Gait Abnormality in Parkinson’s Disease
Objective: To assess the prevalence of tandem gait abnormality in patients with Parkinson’s disease (PD), comparing Hoehn and Yahr (HY) stages 2 and 3. Background:…Pimavanserin Combined With Anti-Dementia Medications for Parkinson Disease Psychosis
Objective: To evaluate the differential antipsychotic effect of pimavanserin, a selective serotonin (5-HT2A) receptor inverse agonist, for Parkinson’s disease psychosis with and without concomitant anti-dementia…Brain Perfusion pattern linked to depressive state in Parkinson’s: An arterial spin labelling MRI study
Objective: To investigate patterns of cerebral blood flow alteration associated with depressive state in Parkinson’s disease (PD) by using principal component analysis of arterial spin…Naturalistic-based UPDRS-III Minimal Clinically Important Difference (MCID) in early PD
Objective: To find the MCID of the UPDRS-III subscale in early PD subjects, when started on a new dopaminergic drug. Background: The concept of Minimally…Pilot study of a new tool to optimize dopaminergic treatment in Parkinson’s disease: The OPTIPARK Scale Project
Objective: Our objective was to develop and pilot test a scale (OPTIPARK) for assessing a patient´s dopaminergic state, allowing the clinician to consider the adjustment…Zonisamide improves parkinsonism in DLB patients: A randomized phase 3 trial
Objective: To verify the efficacy and safety of zonisamide (ZNS) for parkinsonism in patients with dementia with Lewy bodies (DLB). Background: DLB parkinsonism is responsive…A case of early onset parkinsonism caused by PLA2G6 gene mutation
Objective: To report and follow up a case of early-onset parkinsonism (EOP) caused by mutation of PLA2G6 gene and to improve the understanding and treatment…Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment
Objective: We evaluated the screening ability of the Korean version of the Montreal Cognitive Assessment (K-MoCA) in the patients with Parkinson's disease. Background: The Montreal…Quantitative EEG and medial temporal lobe atrophy in early Parkinson’s disease with behavioral and psychological symptoms
Objective: We aimed to assess the relationship between EEG abnormalities and MTLA, and its clinical validity in Parkinson’s disease with behavioral and psychological symptoms. Background:…Dopaminergic impairments following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin through inflammatory cytokines in rats
Objective: Impact of psychological stressors in modulating the toxicity of environmental chemicals has been suggested, however the mechanism this is not clear. Background: Repeated stress…
- « Previous Page
- 1
- …
- 164
- 165
- 166
- 167
- 168
- …
- 177
- Next Page »